BAP Releases New Guidelines on the Pharmacologic Management of Substance Use Disorders

In May, the British Association for Psychopharmacology (BAP) released comprehensive new evidence-based guidelines on the pharmacologic management of substance use disorders. Topics covered include management of withdrawal, opioid agonist therapy, maintaining abstinence, management of substance use disorders in pregnancy, comorbid conditions, and treatment approaches with younger and older people, among others.

The guidelines are available for free download on the BAP website.